Wilma A. Stolk

23.5k total citations
79 papers, 2.4k citations indexed

About

Wilma A. Stolk is a scholar working on Infectious Diseases, Ecology and Parasitology. According to data from OpenAlex, Wilma A. Stolk has authored 79 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Infectious Diseases, 42 papers in Ecology and 36 papers in Parasitology. Recurrent topics in Wilma A. Stolk's work include Parasitic Diseases Research and Treatment (72 papers), Parasite Biology and Host Interactions (42 papers) and Parasites and Host Interactions (36 papers). Wilma A. Stolk is often cited by papers focused on Parasitic Diseases Research and Treatment (72 papers), Parasite Biology and Host Interactions (42 papers) and Parasites and Host Interactions (36 papers). Wilma A. Stolk collaborates with scholars based in Netherlands, United States and United Kingdom. Wilma A. Stolk's co-authors include Sake J. de Vlas, Luc E. Coffeng, J. Dik F. Habbema, María‐Gloria Basáñez, Swaminathan Subramanian, G.J. van Oortmarssen, Martin Walker, T. Déirdre Hollingsworth, Jan Hendrik Richardus and J Remme and has published in prestigious journals such as New England Journal of Medicine, Nature Communications and PLoS ONE.

In The Last Decade

Wilma A. Stolk

77 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wilma A. Stolk Netherlands 31 1.7k 1.2k 1.0k 604 416 79 2.4k
Frank O. Richards United States 37 1.7k 1.0× 1.5k 1.2× 1.0k 1.0× 1.1k 1.8× 484 1.2× 108 3.3k
Paul E. Simonsen Denmark 31 1.9k 1.1× 1.6k 1.3× 1.2k 1.2× 810 1.3× 279 0.7× 112 2.7k
Peter Enyong Cameroon 25 1.4k 0.8× 1.1k 0.9× 950 0.9× 344 0.6× 350 0.8× 81 1.9k
Joseph Kamgno Cameroon 24 1.4k 0.8× 1.3k 1.1× 1.0k 1.0× 378 0.6× 326 0.8× 106 2.4k
Reda M. R. Ramzy Egypt 30 1.6k 0.9× 1.6k 1.3× 1.2k 1.2× 688 1.1× 230 0.6× 88 2.6k
Patrick J. Lammie United States 32 2.3k 1.3× 1.5k 1.3× 1.1k 1.1× 484 0.8× 395 0.9× 82 2.7k
Mounkaïla Noma Burkina Faso 22 1.3k 0.8× 840 0.7× 772 0.8× 318 0.5× 393 0.9× 43 1.6k
James W. Kazura United States 27 1.6k 0.9× 1.1k 0.9× 858 0.8× 485 0.8× 265 0.6× 52 2.1k
Mark Bradley United Kingdom 22 970 0.6× 797 0.7× 466 0.5× 317 0.5× 146 0.4× 38 1.4k
Zulma Medeiros Brazil 23 1.3k 0.8× 915 0.8× 596 0.6× 486 0.8× 231 0.6× 119 1.8k

Countries citing papers authored by Wilma A. Stolk

Since Specialization
Citations

This map shows the geographic impact of Wilma A. Stolk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wilma A. Stolk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wilma A. Stolk more than expected).

Fields of papers citing papers by Wilma A. Stolk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wilma A. Stolk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wilma A. Stolk. The network helps show where Wilma A. Stolk may publish in the future.

Co-authorship network of co-authors of Wilma A. Stolk

This figure shows the co-authorship network connecting the top 25 collaborators of Wilma A. Stolk. A scholar is included among the top collaborators of Wilma A. Stolk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wilma A. Stolk. Wilma A. Stolk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stolk, Wilma A., et al.. (2026). WHO’s Global status report on neurology: mixed messages for people with headache disorders. The Journal of Headache and Pain. 27(1). 37–37.
2.
Kura, Klodeta, Wilma A. Stolk, María‐Gloria Basáñez, et al.. (2024). How Does the Proportion of Never Treatment Influence the Success of Mass Drug Administration Programs for the Elimination of Lymphatic Filariasis?. Clinical Infectious Diseases. 78(Supplement_2). S93–S100. 6 indexed citations
3.
Touloupou, Panayiota, Claudio Fronterrè, Jorge Cano, et al.. (2024). An Ensemble Framework for Projecting the Impact of Lymphatic Filariasis Interventions Across Sub-Saharan Africa at a Fine Spatial Scale. Clinical Infectious Diseases. 78(Supplement_2). S108–S116. 3 indexed citations
4.
Coffeng, Luc E., et al.. (2024). Predictive Value of Microfilariae-Based Stop-MDA Thresholds After Triple Drug Therapy With IDA Against Lymphatic Filariasis in Treatment-Naive Indian Settings. Clinical Infectious Diseases. 78(Supplement_2). S131–S137. 3 indexed citations
5.
Biamonte, Marco A., Paul T. Cantey, Yaya Ibrahim Coulibaly, et al.. (2022). Onchocerciasis: Target product profiles of in vitro diagnostics to support onchocerciasis elimination mapping and mass drug administration stopping decisions. PLoS neglected tropical diseases. 16(8). e0010682–e0010682. 8 indexed citations
6.
Prada, Joaquín M., Wilma A. Stolk, Emma L. Davis, et al.. (2021). Delays in lymphatic filariasis elimination programmes due to COVID-19, and possible mitigation strategies. Transactions of the Royal Society of Tropical Medicine and Hygiene. 115(3). 261–268. 16 indexed citations
7.
Stolk, Wilma A., David J. Blok, Jonathan I. D. Hamley, et al.. (2021). Scaling-Down Mass Ivermectin Treatment for Onchocerciasis Elimination: Modeling the Impact of the Geographical Unit for Decision Making. Clinical Infectious Diseases. 72(Supplement_3). S165–S171. 5 indexed citations
8.
Vos, Anneke S. de, Wilma A. Stolk, Luc E. Coffeng, & Sake J. de Vlas. (2021). The impact of mass drug administration expansion to low onchocerciasis prevalence settings in case of connected villages. PLoS neglected tropical diseases. 15(5). e0009011–e0009011. 7 indexed citations
9.
Melchers, Natalie V. S. Vinkeles, Wilma A. Stolk, Michele E. Murdoch, et al.. (2021). How does onchocerciasis-related skin and eye disease in Africa depend on cumulative exposure to infection and mass treatment?. PLoS neglected tropical diseases. 15(6). e0009489–e0009489. 5 indexed citations
10.
Behrend, Matthew R., María‐Gloria Basáñez, Jonathan I. D. Hamley, et al.. (2020). Modelling for policy: The five principles of the Neglected Tropical Diseases Modelling Consortium. PLoS neglected tropical diseases. 14(4). e0008033–e0008033. 51 indexed citations
11.
Hamley, Jonathan I. D., David J. Blok, Martin Walker, et al.. (2020). What does the COVID-19 pandemic mean for the next decade of onchocerciasis control and elimination?. Transactions of the Royal Society of Tropical Medicine and Hygiene. 115(3). 269–280. 18 indexed citations
12.
Melchers, Natalie V. S. Vinkeles, Luc E. Coffeng, Michel Boussinesq, et al.. (2020). Projected Number of People With Onchocerciasis-Loiasis Coinfection in Africa, 1995 to 2025. Data Archiving and Networked Services (DANS). 18 indexed citations
13.
Melchers, Natalie V. S. Vinkeles, Luc E. Coffeng, Sake J. de Vlas, & Wilma A. Stolk. (2020). Standardisation of lymphatic filariasis microfilaraemia prevalence estimates based on different diagnostic methods: a systematic review and meta-analysis. Parasites & Vectors. 13(1). 302–302. 4 indexed citations
14.
Pion, Sébastien D. S., Hugues C. Nana-Djeunga, Cédric B. Chesnais, et al.. (2019). Implications for annual retesting after a test-and-not-treat strategy for onchocerciasis elimination in areas co-endemic with Loa loa infection: an observational cohort study. The Lancet Infectious Diseases. 20(1). 102–109. 21 indexed citations
15.
Tekle, Afework Hailemariam, Honorat Zouré, Mounkaïla Noma, et al.. (2017). Progress towards onchocerciasis elimination in the participating countries of the african program for onchocerciasis control : epidemiological evaluation results. American Journal of Tropical Medicine and Hygiene. 95(5). 1–1. 1 indexed citations
16.
Coffeng, Luc E., Sake J. de Vlas, Allison Golden, et al.. (2017). Modelling Anti-Ov16 IgG4 Antibody Prevalence as an Indicator for Evaluation and Decision Making in Onchocerciasis Elimination Programmes. PLoS neglected tropical diseases. 11(1). e0005314–e0005314. 34 indexed citations
18.
Stolk, Wilma A., Chris Stone, & Sake J. de Vlas. (2015). Modelling Lymphatic Filariasis Transmission and Control: Modelling Frameworks, Lessons Learned and Future Directions. Advances in Parasitology. 87. 249–291. 28 indexed citations
19.
Kim, Young‐Eun, J Remme, Peter Steinmann, et al.. (2015). Control, Elimination, and Eradication of River Blindness: Scenarios, Timelines, and Ivermectin Treatment Needs in Africa. PLoS neglected tropical diseases. 9(4). e0003664–e0003664. 79 indexed citations
20.
Stolk, Wilma A., G.J. van Oortmarssen, Sake J. de Vlas, et al.. (2005). EFFECTS OF IVERMECTIN AND DIETHYLCARBAMAZINE ON MICROFILARIAE AND OVERALL MICROFILARIA PRODUCTION IN BANCROFTIAN FILARIASIS. American Journal of Tropical Medicine and Hygiene. 73(5). 881–887. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026